Medidata Solutions, a provider of SaaS clinical development solutions that enhance the efficiency of customers' clinical trials, has reported total revenues of $40.76m for the first quarter ended 31 March 2011, compared to $37.64m for the same period in 2010.
Subscribe to our email newsletter
The company has reported a net income of $3.19m, or $0.13 loss per diluted share, compared to net income of $1.86m or $0.08 per diluted share, for the same period last year.
Medidata Solutions’ operating income was $3.47m, as compared to $2.94m for the same period prior year.
Gross profit was $27.67m, as compared to $25.07m for the same period in 2010.
Medidata Solutions chief financial officer and executive vice president Bruce Dalziel said they have established a steady and consistent track record of gross margin expansion, high renewal rates and overall profitable growth.
"As reflected in our first quarter results, 2011 is expected to be a good year in terms of profitability and operating cash flow growth," Dalziel said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.